| Previous Close | 0.37 |
| Open | 0.36 |
| Day High | 0.37 |
| Day Low | 0.36 |
| 52-Week High | 6.23 |
| 52-Week Low | 0.28 |
| Volume | 269,800 |
| Average Volume | 7.58M |
| Market Cap | 3.71M |
| PE | -0.26 |
| EPS | -1.36 |
| Moving Average 50 Days | 0.44 |
| Moving Average 200 Days | 1.12 |
| Change | -0.01 |
Soligenix Inc. (NASDAQ: SNGX) Advancing Rare-Disease Therapies Positioned at Pivotal Crossroad
GlobeNewswire Inc.
Dec 05, 2025 1:30 PM GMT
NEW YORK, Dec. 05, 2025 (GLOBE NEWSWIRE) -- via BioMedWire: — Soligenix Inc. (NASDAQ: SNGX) today announces its placement in an editorial published by BioMedWire ("BMW"), one of 75+ brands within the Dynamic Brand Portfolio@IBN (InvestorBrandNetwor
Soligenix Inc. (NASDAQ: SNGX) Proprietary Platform Aims to Meet Growing Need for Effective CTCL Therapy
GlobeNewswire Inc.
Aug 07, 2025 12:30 PM GMT
NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — Soligenix Inc. (NASDAQ: SNGX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 70+ brands within the Dynamic Brand Portfolio@IBN (InvestorBrand
Soligenix Inc. (NASDAQ: SNGX) Innovative Platform Provides Novel Treatment for Underserved CTCL Space
GlobeNewswire Inc.
Aug 05, 2025 12:30 PM GMT
NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — Soligenix Inc. (NASDAQ: SNGX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 70+ brands within the Dynamic Brand Portfolio@IBN (InvestorBrand